Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 54.73 billion as of March 9, 2026. Its market cap has decreased by -59.26% in one year.

Market Cap

54.73B

Enterprise Value

270.76B

Revenue

74.91B

Ranking

n/a

PE Ratio

n/a

Stock Price

281.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 54.73B, an increase of 1,620.69%. That is a compound annual growth rate of 9.88%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	54.73B	-46.63%
Dec 30, 2025	102.54B	-21.60%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MYUNGMOON Pharm co.,Ltd	59.50B
Yuyu Pharma	68.19B
Enzychem Lifesciences	85.55B
Kukje Pharma	100.69B
CKD Bio	109.66B
Ildong Holdings	121.95B
Kyongbo Pharmaceutical	132.92B
Jeil Pharma Holdings	134.94B

Market Cap Rankings